Disease | chronic mucocutaneous candidiasis |
Phenotype | C0006840|candidiasis |
Sentences | 1 |
PubMedID- 24260135 | Another potential application of myriocin could be for topical antifungal treatment as in superficial candidiasis, in particular, in patients with chronic mucocutaneous candidiasis (cmc) who suffer from a selective immune deficiency with increased susceptibility to superficial candidal infections [33]. |
Page: 1